BioImagene Obtains $26,000,000 Series D Funding

  • Feed Type
  • Date
    8/20/2008
  • Company Name
    BioImagene
  • Mailing Address
    919 Hermosa Ct. Sunnyvale, CA 94085
  • Company Description
    In the life sciences and healthcare industry, two-thirds of the data is in the form of images. The process of extracting meaningful information and knowledge from image data is still manual, inefficient, inaccurate and expensive. At BioImagene, our business is to combine the innovations in biological sciences and computing technology to develop scientific image informatics solutions for automating the analysis of images that span across gels, cells, tissues and whole body images.

    BioImagene is pioneering innovative solutions in the life sciences and digital pathology markets targeted to the specific needs of pathologists, researchers and drug developers. We believe that applying image informatics solutions can significantly boost productivity, ensure accuracy and efficiency and reduce bottlenecks in all aspects of life science workflows.

    Our clear competitive advantage comes from the combination of our deep domain knowledge, enterprise standard technology solutions and our globa

  • Website
    http://www.bioimagene.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $26,000,000
  • Transaction Round
    Series D
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Burrill & Company
  • Venture Investor
    Ascension Health Ventures
  • Venture Investor
    National Healthcare Services
  • Venture Investor
    Artiman Ventures